Radar | Apr 25,2020
Oct 23 , 2021
By BERSABEH GEBRE ( FORTUNE STAFF WRITER )
Awash Insurance S.C. plans to start a clinical-trial coverage policy, submitted its proposal to the insurance supervision directorate at the National Bank of Ethiopia (NBE) last month.
If permitted, Awash will be the second insurance firm following the Ethiopian Insurance Corporation (EIC), the state-owned industry giant. Industry insiders see diversifying products as key to growth in the industry characterised by cut-throat price competition and low penetration of insurance policies.
A clinical-trail insurance policy provides coverage for participants of clinical trials, who are compensated for risking injury, disease or death in controlled studies and researches. Awash has been preparing its policy for nearly a month, setting a goal to generate up to 15 million Br in annual premiums, says Gudissa Legesse, CEO of Awash Insurance. It is five times higher than the target set by EIC from a similar product. Gudissa saw the firm's gross written premiums surpassing one billion Birr last year, the first among 17 private insurers, with over 30 life and non-life insurance products.
"The coverage will help researchers save on foreign currency," said the CEO, who expects no underwriting profit during the first year.
The 26-year old firm focused on research centres such as the Armauer Hansen Research Institute, the Addis Abeba University College of Health Sciences, the Ethiopian Public Health Institute and public universities.
"Researchers have asked us to introduce this policy many times," Gudissa told Fortune.
Clinical trials conducted in Ethiopia buy insurance coverage from firms abroad, where policies cost up to 14,000 euros.
Abebaw Fekadu is a professor of psychiatry at Addis Abeba University and director of the Africa Centre of Excellence for Innovative Drug Development & Therapeutic Trials. He believes the policy could help researchers cut down on forex expenditures but would have other benefits. The low risk involved for insurance firms, as the health and safety of participants is a priority in any clinical trial, could encourage them to offer the product, according to Abebaw.
"Insurance is crucial to fostering clinical trials and research," he said.
Awash, which registered 210 million Br in profits last year, does not plan to involve a reinsurer in its clinical trial policy, says Gudissa.
"The market is not big," he said.
The clinical trial policy is the second product Awash Insurance is introducing this year after offering mobile phone insurance coverage. Other firms say clinical trial policies are not worth their effort, as there is no market for them.
Founded in 1995, Nyala Insurance, which also launched a mobile phone insurance policy earlier this year, is one such firm. Yared Molla, CEO of Nyala, believes that although there have been requests from research institutions, the company has no plans to get into the business.
"The firm will focus on policies that have more demand," said Yared.
In countries like Ethiopia, where there is a low-resource setting, conducting a clinical trial is expensive and financed by funders and international agencies such as the World Health Organisation (WHO).
The lack of expanding market is attributed to insufficient marketing, according to Fikru Tsegye, executive officer for strategy and business development at Ethiopian Reinsurance (EthioRe).
"New policies could collapse if the public has no awareness," said Fikru.
PUBLISHED ON Oct 23,2021 [ VOL 22 , NO 1121]
Radar | Apr 25,2020
Radar | Mar 09,2019
Featured | Jan 28,2023
Radar | Jun 26,2021
Fortune News | Jan 23,2021
Radar | Apr 22,2022
Radar | Jun 01,2019
Fortune News | Jan 16,2021
Fortune News | Jan 26,2019
Radar | Dec 25,2021
Dec 24 , 2022
Biniam Mikru heads the department of cabinet affairs under Mayor Adanech Abiebie. But...
Jul 2 , 2022 . By RUTH TAYE
On a rainy afternoon last week, a coffee processing facility in the capital's Akaki-Qality District was abuzz with activ...
Nov 27 , 2021
Against my will, I have witnessed the most terrible defeat of reason and the most sa...
Nov 13 , 2021
Plans and reality do not always gel. They rarely do in a fast-moving world. Every act...
Leaders of the National Election Board are in a charm offensive mood, of a sort. Last week, they organised a rare tour for members of the me...
When the country's most senior diplomats and envoys return back to their posts after two-week debriefings, they leave behind a point or two...
Feb 4 , 2023
Rene Lefort is a French journalist with a keen interest in Ethiopia, spanning over ha...
Jan 28 , 2023
It is not common to see an appointment for a senior federal government office stir de...
Jan 21 , 2023
Eyob Tekalign, state minister for Finance, took to social media platforms last week t...
Jan 14 , 2023
The longing for normalcy and a semblance of individual and collective security in Eth...
Folks awed by the devastating national exam results have ignored the massive crisis that engulf the academic sector for nearly half a centur...
Inspired by the stories of business people who started small, I have been on the quest to decode the custom-made recipe of wealth for th...
Or see contact page